Evidence map›Paper›PMID 32275202›Full record

ArticleBehavioral medicine (Washington, D.C.)

Delay Discounting, Glycemic Regulation and Health Behaviors in Adults with Prediabetes.

Leonard H Epstein, Rocco A Paluch, Jeffrey S Stein, Teresa Quattrin, Lucy D Mastrandrea, Kyle A Bree, Yan Yan Sze, Mark H Greenawald, Mathew J Biondolillo, Warren K Bickel

Abstract read
In one paragraph

Article in Behavioral medicine (Washington, D.C.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Perceived reward certainty in the assessment of delay discounting.Journal of the experimental analysis of behavior · 2025
    Article
  9. Delay discounting and symptoms of anxiety and depression in adolescents experiencing challenges with managing type 1 diabetes.Children's health care : journal of the Association for the Care of Children's Health · 2025
    Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Leonard H EpsteinJacobs School of Medicine and Biomedical Sciences, University at Buffalo.
Rocco A PaluchJacobs School of Medicine and Biomedical Sciences, University at Buffalo.
Jeffrey S SteinVirginia Tech Carilion Research Institute.
Teresa QuattrinJacobs School of Medicine and Biomedical Sciences, University at Buffalo.
Lucy D MastrandreaJacobs School of Medicine and Biomedical Sciences, University at Buffalo.
Kyle A BreeJacobs School of Medicine and Biomedical Sciences, University at Buffalo.
Yan Yan SzeJacobs School of Medicine and Biomedical Sciences, University at Buffalo.
Mark H GreenawaldVirginia Tech Carilion Research Institute.
Mathew J BiondolilloJacobs School of Medicine and Biomedical Sciences, University at Buffalo.
Warren K BickelVirginia Tech Carilion Research Institute.

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Delay discounting as a target for self-regulation in prediabetesUH2DK109543 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BICKEL, WARREN K, EPSTEIN, LEONARD H · 2015 to 2017
$2.4M
Delay discounting as a target for self-regulation in prediabetesUH3DK109543 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BICKEL, WARREN K, EPSTEIN, LEONARD H · 2018 to 2019
$2.0M
NCATS NIH HHS UL1 TR001412NIDDK NIH HHS P30 DK111022NIDDK NIH HHS UH2 DK109543NIDDK NIH HHS UH3 DK109543
6 · The paper itself

Abstract

The majority of people with prediabetes transition to type 2 diabetes. Research has suggested that persons with type 2 diabetes are likely to discount the future and focus on immediate rewards. This study was designed to assess whether this process of delay discounting (DD) is associated with glycemic regulation, medication adherence and eating and exercise behaviors in adults with prediabetes. Participants included 81 adults with prediabetes who were also prescribed hypertension or dyslipidemia drugs, which is common for people with prediabetes. Participants completed adjusting amount DD $100 and $1000 tasks, as well assessments of glycemic control (Hemoglobin (Hb) A1c), medication adherence, diet quality, and objectively measured physical activity. Relationships between DD and these variables were assessed. Results showed higher rates of DD were related to higher HbA1c; as well as poorer medication adherence, lower diet quality and lower physical activity. Hierarchical regression showed that the association between minority status, a known risk factor for type 2 diabetes, was moderated by DD, as minorities with higher DD had greater HbA1c values. Delay discounting may represent a novel target to prevent progression from prediabetes to type 2 diabetes.

Indexed as

Delay DiscountingDiabetes Mellitus, Type 2Prediabetic StateAdultBlood GlucoseHealth BehaviorHumansBlood Glucosedelay discountingdiet qualityglycemic controlmedication adherencephysical activityprediabetes

Identifiers

PMID32275202
PMCPMC8462992

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.